Jupiter Life Line Hospitals: quarterly growth and Rs 150 crore Pune land deal

Results restatedResults View source PDF Explain this filing

JLHL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.7%Reaction day

₹243.05

prior close

₹248.65

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+3.3% vs market

Hospital peers, median of 27sector+1.4%+2.3% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 2.3 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.6

10m

-1.2

15m

-1.0

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.7+0.4+3.3+1.4+2.3

Next day

+5.1+2.1+3.0+3.3+1.8

+6.1+2.2+3.9+3.2+2.9

+7.0+2.9+4.1+4.2+2.8

+7.8+0.3+7.5+5.1+2.7

+7.8+1.8+6.0+3.8+4.0

+15.6+4.2+11.4+10.1+5.6

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

For the consolidated quarter ended September 30, 2026, revenue was Rs 239.68 crore versus Rs 193.63 crore a year earlier, up 23.8%, and profit after tax was Rs 20.20 crore versus Rs 13.18 crore, up 53.3%. For the six months ended September 30, 2026, consolidated revenue was Rs 456.50 crore and profit after tax was Rs 37.49 crore. The board approved a wholly owned healthcare subsidiary and agreed to buy Pune land for Rs 150 crore.

Likely market impact

Revenue and profit growth is positive, and the land may support expansion, but the Rs 150 crore purchase could raise cash needs and debt.

By the numbersConsolidated · Q2 FY27 vs Q2 FY26

	Q2 FY27	Q2 FY26	Change
Revenue	₹456.5 Cr	₹393.6 Cr	+16.0%
Operating profit	₹64.54 Cr	₹62.95 Cr	+2.5%
Profit after tax	₹56.36 Cr	₹57.48 Cr	−1.9%
EBITDA margin	23.4%	23.4%	−0.0 pp

From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.